Use of rocuronium and sugammadex for video-assisted thoracoscopic surgery is associated with reduced duration of chest tube drainage: a propensity score-matched analysis

The Impact of Rocuronium and Sugammadex on Length of Stay in Patients Undergoing Open Spine Surgery: A Propensity Score-Matched Analysis

“…Sugammadex, contingent on the dosage, can effectively reverse moderate, deep, and profound blocks engendered by rocuronium [ 25 ]. This action assists in preventing residual neuromuscular blockade, thereby mitigating postoperative chest radiographic abnormalities [ 26 , 27 ], in addition to minor and major pulmonary complications [ 28 , 29 ]. According to the literature search to date, the role of sugammadex in the LOS in spine surgery has not yet been extensively studied and concluded.…”

Commentary on “An appraisal of neostigmine versus sugammadex for neuromuscular blockade reversal in patients with a prior heart transplant”

“…With the increasing number of cardiac transplants worldwide, this article presents a meaningful conclusion. There is a lot of recent evidence suggesting that the incidence of post-operative pulmonary complications (POPC) is lower with the use of sugammadex as compared to neostigmine [ 2 , 3 ]. Pulmonary complications are frequent after cardiac transplant [ 4 ], and it is not illogical to assume that post-cardiac transplant patients may be prone to develop POPC.…”